All times shown are PDT (GMT-7) (San Francisco)

Displaying One Session

Prime Channel-Live sessions

Oral abstract session
Room
Prime Channel-Live sessions
Oral abstract session

OAXLB0101 - HPTN083 interim results: Pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is safe and highly effective for cisgender men and transgender women who have sex with men (MSM,TGW)

Oral abstract session

OAXLB0102 - Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana

Room
Prime Channel-Live sessions
Oral abstract session

OAXLB0103 - Community HIV testing continuity in the context of COVID-19 lockdown and social distancing

Room
Prime Channel-Live sessions
Oral abstract session

OAXLB0104 - The ADVANCE trial: Phase 3, randomised comparison of TAF/FTC+DTG, TDF/FTC+DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infection

Room
Prime Channel-Live sessions
Oral abstract session

OAXLB0105 - The first long-term remission of chronic HIV-1 infection without myeloablation?

Room
Prime Channel-Live sessions
Oral abstract session

OAXLB0106 - Western Cape: COVID-19 and HIV / Tuberculosis

Room
Prime Channel-Live sessions